Use of antagonist peptides to inhibit in vitro T cell responses to Par j1,the major allergen of Parietaria judaica pollen

Citation
R. De Palma et al., Use of antagonist peptides to inhibit in vitro T cell responses to Par j1,the major allergen of Parietaria judaica pollen, J IMMUNOL, 162(4), 1999, pp. 1982-1987
Citations number
35
Categorie Soggetti
Immunology
Journal title
JOURNAL OF IMMUNOLOGY
ISSN journal
00221767 → ACNP
Volume
162
Issue
4
Year of publication
1999
Pages
1982 - 1987
Database
ISI
SICI code
0022-1767(19990215)162:4<1982:UOAPTI>2.0.ZU;2-4
Abstract
Antigenic peptides with substituted side chains inhibit immune responses to a number of recall Ags from infectious agents in vitro. Here we show that the same strategy can be applied to peptides derived from a pollen protein, the major allergen of Parietaria judaica (Par j1), a plant responsible for most allergenic sensitization in the southern Mediterranean area. Three T cell lines responding to Par j1 protein were used to identify a stimulatory peptide, Two different monosubstituted altered peptide ligands (APL) were identified that bound to the HLA-DR of the responders, did not stimulate th e T cell lines on their own, and decreased the response to subsaturating am ounts of the unmodified stimulatory peptide, Most important, these APL were able to inhibit the response of these cell lines to intact Par j1 protein, A third monosubstituted peptide bound to the HLA-DR but did not show inhib itory activity. The two APL had a lower affinity than the unsubstituted pep tide for the HLA-DR, The last two observations make MHC blockade an unlikel y explanation for the observed effect. These results indicate the action of a specific peptide-mediated antagonism that may be useful in controlling t he T cell component of an allergic response.